Corporate-Backed Blue Dogs Threaten Democrats’ Budget Plan Facing health care and climate crises, a group of six conservative House Democrats are seeking to pump the brakes on the largest federal investments in decades.
Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs, House Report Finds The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
Democrats Work to Finalize Infrastructure Package Democrats have given themselves just a few weeks to pass a preliminary budget resolution for one of two infrastructure bills moving in tandem.
Fact Check: Does Bernie Sanders Get Support From Big-Money Super PACs? Elizabeth Warren lumped Sanders in with fellow contenders who are getting millions of dollars worth of help from outside groups funded by corporate executives.